Addus HomeCare (ADUS) Stock: Buy, Sell, or Hold?
ADUS - Addus HomeCare Corp.
$117.09
-1.43 (-1.21%)
▼
5d:
-1.35%
30d:
-0.82%
90d:
+25.85%
HOLD
MODERATE Confidence
Analysis Updated: Sep 11, 2026 12:00 AM ET
Earnings: Nov 02, 2026
Get Alerted When ADUS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: ADUS is fairly valued with market pricing in 2.4% annual growth. Fine to hold or accumulate slowly on dips.
📊 HOLD: ADUS is fairly valued with market pricing in 2.4% annual growth. Fine to hold or accumulate slowly on dips.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$141.47
Based on 5.4% avg growth
INTRINSIC VALUE TODAY
$87.84
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 14.5x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: ADUS is currently trading at $117.09, which is considered fair relative to its 30-day fair value range of $115.99 to $120.07. The stock's valuation (Forward PE: 15.6) is in line with its historical norms (14.5). At these levels, the market is pricing in 2.4% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, ADUS is in a strong uptrend. The price is currently testing key support at $114.29. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock scores a mixed 56/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $134.69 (+15.0%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, ADUS is in a strong uptrend. The price is currently testing key support at $114.29. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock scores a mixed 56/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $134.69 (+15.0%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$115.99 -
$120.07
Company Quality Score
56/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
71.0%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (56/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($134.69)
- NEUTRAL: Market pricing in 2.4% annual earnings growth - fairly valued
- NEUTRAL: Bottoming setup forming (56/100) — watch for confirmation
Trading Range Analysis
30-Day Trading Range
$115.99 -
$120.07
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$114.29
Resistance Level
$120.58
Current Trend
Strong Uptrend
Technical data as of
Sep 11, 2026
Fundamental Context
Forward P/E (Next Year Est.)
15.57
Wall Street Target
$134.69
(+15.0%)
Revenue Growth (YoY)
8.0%
Earnings Growth (YoY)
24.2%
Profit Margin
7.1%
Valuation Premium vs History
+2.4% premium
PE vs Historical
15.6 vs 14.5
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+2.4%
(market-implied from PE analysis)
1-Year Target
$119.90
(+2%)
2-Year Target
$122.78
(+5%)
3-Year Target
$125.72
(+7%)
3-Yr Target (if PE normalizes)
(PE: 16→15)
PE COMPRESSION
$117.08
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.2, Growth: 6.7%)
$184.45
(+58%)
Base:
(SPY PE: 15.6, Growth: 6.7%)
$142.39
(+22%)
Bear:
(PE: 13.2, Growth: 6.7%)
$121.03
(+3%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (21x PE), but valuation improves significantly next year (16x PE) as earnings recover.
Trailing PE: 20.76 | Current EPS (TTM): $5.71
Bull Case
$171.69
(+47%)
Analyst growth 31.7%, PE expands to 22.8
Base Case
$156.09
(+33%)
Market implied 31.7%, PE stable at 20.8
Bear Case
$80.59
(-31%)
Severe decline -20.0%, PE contracts to 17.6
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: September 11, 2026 7:52 PM ET
Data refreshes hourly during market hours. Next update: 8:52 PM
Data refreshes hourly during market hours. Next update: 8:52 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ADUS showing a specific setup today?
Insider Activity (6 Months)
0
Buys
1
Sells
Net
INSIDERS SELLING
Recent Transactions
Cliff Donald Blessing
SELL
178 shares
2026-04-21
Top Rated Medical Care Facilities Stocks
Top-rated stocks in Medical Care Facilities by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
THC
Tenet Healthcare Corpora… |
STRONG BUY
22 analysts |
$285 | 61 BUY |
|
HCA
HCA Healthcare, Inc. |
BUY
25 analysts |
$451 | 50 HOLD |
|
EHC
Encompass Health Corp |
STRONG BUY
12 analysts |
$148 | 55 HOLD |
|
CMPS
Compass Pathways Plc |
STRONG BUY
11 analysts |
$24 | 52 HOLD |
|
CON
Concentra Group Holdings… |
STRONG BUY
8 analysts |
$40 | 60 BUY |
